Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are hitting U.S. pharmacies. But how will they be prescribed? A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions.

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access Shape Patient Choices as MEDVi Lists Compounded GLP-1 Programs Starting at

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with telehealth and retail platform.

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Wegovy ...

The agency greenlit an oral version of the obesity drug Wegovy. By Dani Blum The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering patients who fear or are uncomfortable with needles a more ...

Dec 22 (Reuters) – The U.S. Food and Drug Administration approved Novo Nordisk’s weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from ...